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Background: Many of the molecular mechanisms underlying the development and progression of metabolic diseases remain unclear. High 
throughput molecular profiling represents a powerful tool to identify biologic pathways involved in such complex human diseases. We hypothesized 
that this approach would provide insight into markers of insulin resistance and glycemic control.
methods: Genomewide association studies (GWAS) were performed on training (n=2468) and validation (n=783) cohorts in the CATHGEN 
cardiovascular biorepository at Duke University. Linear regression was used to test the association of genotype with glycated albumin (which is 
correlated with hemoglobin A1c and represents insulin resistance and glycemic control in non-diabetic and diabetic individuals, respectively). 
Analysis was adjusted for age, sex and race. Quantitative whole genome RNA profiling using the Illumina Human HT-12 v3 Expression BeadChip 
was performed on 1194 CATHGEN subjects. Expression quantitative trait loci (eQTL) analysis was used to associate glycated albumin and gene 
expression. Gene set enrichment analysis (GSEA) was performed to highlight biologic pathways associated with glycated albumin.
results: Several single nucleotide polymorphisms had nominal association with glycated albumin (p<5e-4 in training cohort, p<0.05 in validation 
cohort) including many genes reporting on intracellular protein trafficking, endoplasmic reticulum-associated degradation (ERAD) and ubiquitin 
proteasome pathways. eQTL analysis likewise revealed several loci involved in endoplasmic reticulum protein processing and ERAD (HSPA8, 
DNAJB14, YIPF5, SEC61B, HSP90B1) and ubiquitin proteasome pathways (UBAP2L, VPS28, JOSD2). The proteasome pathway was the top pathway 
associated with gylcated albumin in GSEA (nominal p<0.05).
conclusion: Defects in ERAD and ubiquitin proteasome pathways have been associated with metabolic diseases including obesity and diabetes. 
Using combined omics platforms we have associated these biologic pathways with glycated albumin, a marker of insulin resistance and glycemic 
control. The pathophysiologic significance of these results remains to be explored.
